These novel medications , Tirzepatide , represent a groundbreaking advancement in managing obesity and possibly associated conditions . They are grouped as GLP-1 hormone agonists , indicating they function to mimic the natural GLP-1 peptide, stimulating glucose secretion and reducing food intake. Although Retatrutide each works largely similarly, t